{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:09:06Z","timestamp":1787159346579,"version":"build-2736575974"},"reference-count":174,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The enzyme N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) was originally identified as a lysosomal enzyme which was deficient in Mucopolysaccharidosis VI (MPS VI; Maroteaux-Lamy Syndrome). The newly directed attention to the impact of ARSB in human pathobiology indicates a broader, more pervasive effect, encompassing roles as a tumor suppressor, transcriptional mediator, redox switch, and regulator of intracellular and extracellular-cell signaling. By controlling the degradation of chondroitin 4-sulfate and dermatan sulfate by removal or failure to remove the 4-sulfate residue at the non-reducing end of the sulfated glycosaminoglycan chain, ARSB modifies the binding or release of critical molecules into the cell milieu. These molecules, such as galectin-3 and SHP-2, in turn, influence crucial cellular processes and events which determine cell fate. Identification of ARSB at the cell membrane and in the nucleus expands perception of the potential impact of decline in ARSB activity. The regulation of availability of sulfate from chondroitin 4-sulfate and dermatan sulfate may also affect sulfate assimilation and production of vital molecules, including glutathione and cysteine. Increased attention to ARSB in mammalian cells may help to integrate and deepen our understanding of diverse biological phenomenon and to approach human diseases with new insights.<\/jats:p>","DOI":"10.3390\/ijms232113146","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T07:26:50Z","timestamp":1667114810000},"page":"13146","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7220-3419","authenticated-orcid":false,"given":"Joanne K.","family":"Tobacman","sequence":"first","affiliation":[{"name":"Jesse Brown VA Medical Center, University of Illinois at Chicago, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Jesse Brown VA Medical Center, University of Illinois at Chicago, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"key":"ref_1","first-page":"20150","article-title":"Sequential degradation of chondroitin sulfate in molluscs","volume":"265","author":"DeSousa","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/S0021-9258(17)30223-5","article-title":"Chondroitin SO4 catabolism in chick embryo chondrocytes","volume":"254","author":"Glaser","year":"1979","journal-title":"J. Biol. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/bj1790007","article-title":"Sequential degradation of a chondroitin sulfate disaccharide by lysosomal enzymes from embryonic-chick epiphysial cartilage","volume":"179","author":"Ingmar","year":"1979","journal-title":"Biochem. J."},{"key":"ref_4","first-page":"1811","article-title":"Arylsulphatase B, an exo-sulphatase for chondroitin 4-sulphate tetrasaccharide","volume":"359","author":"Gorham","year":"1978","journal-title":"Hoppe Seylers Z Physiol. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0008-6215(00)90341-0","article-title":"The effect of penultimate N-acetylgalactosamine 4-sulfate on chondroitin chain elongation","volume":"151","author":"Cogburn","year":"1986","journal-title":"Carbohyd. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archpedi.1973.02110190597003","article-title":"Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome). I. Sulfatase B deficiency in tissues","volume":"126","author":"Stumpf","year":"1973","journal-title":"Am. J. Dis. Child."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0006-291X(74)80001-X","article-title":"Arylsulfatase B deficiency in Maroteaux-Lamy syndrome cultured fibroblasts","volume":"59","author":"Fluharty","year":"1974","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0006-291X(74)80446-8","article-title":"Deficiency of chondroitin sulfate N-acetylgalactosamine 4-sulfate sulfatase in Maroteaux-Lamy syndrome","volume":"61","author":"Matalon","year":"1974","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/0006-291X(74)90435-5","article-title":"Maroteaux-Lamy disease (mucopolysaccharidosis VI), subtype A: Deficiency of a N-acetylgalactosamine-4-sulfatase","volume":"60","author":"Cantz","year":"1974","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"D\u2019Avanzo, F., Zanetti, A., De Filippis, C., and Tomanin, R. (2021). Mucopolysaccharidosis Type VI, an updated overview of the disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413456"},{"key":"ref_11","first-page":"1849","article-title":"Une nouvelle dysostose avec elimination urinaire de chondroitine sulfate B","volume":"71","author":"Maroteaux","year":"1963","journal-title":"Presse Med."},{"key":"ref_12","unstructured":"UniProt (2022, October 12). P15848 \u2022 ARSB_HUMAN. Available online: https:\/\/www.uniprot.org\/uniprotkb\/P15848\/entry."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0925-4439(00)00051-X","article-title":"Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition","volume":"1502","author":"Theocharis","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bhattacharyya, S., Feferman, L., and Tobacman, J.K. (2016). Inhibition of phosphatase activity follows decline in sulfatase activity and leads to transcriptional effects through sustained phosphorylation of transcription factor MITF. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153463"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0969-2126(97)00185-8","article-title":"Structure of a human lysosomal sulfatase","volume":"5","author":"Bond","year":"1997","journal-title":"Structure"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1107\/S0907444995005191","article-title":"Crystallization and preliminary characterization of human recombinant N-acetylgalactosamine-4-sulfatase","volume":"51","author":"Ashby","year":"1995","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1042\/bj2480755","article-title":"Human N-acetylgalactosamine-4-sulphate sulphatase. Purification, monoclonal antibody production and native and subunit Mr values","volume":"248","author":"Gibson","year":"1987","journal-title":"Biochem. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/bj3070457","article-title":"Two site-directed mutations abrogate enzyme activity but have different effects on the conformation and cellular content of the N-acetylgalactosamine 4-sulphatase protein","volume":"307","author":"Brooks","year":"1995","journal-title":"Biochem. J."},{"key":"ref_19","unstructured":"GeneCards (2022, October 12). ARSB. Available online: https:\/\/www.genecards.org\/cgi-bin\/carddisp.pl?gene=ARSB&keywords=arylsulfatase,b."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1515\/bchm3.1993.374.1-6.327","article-title":"Structure of the human arylsulfatase B gene","volume":"374","author":"Modaressi","year":"1993","journal-title":"Biol. Chem. Hoppe Seyler."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-5793(98)00065-9","article-title":"Conversion of cysteine to formylglycine in eukaryotic sulfatases occurs by a common mechanism in the endoplasmic reticulum","volume":"423","author":"Dierks","year":"1998","journal-title":"FEBS Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1073\/pnas.0507592102","article-title":"A general binding mechanism for all human sulfatases by the formylglycine-generating enzyme","volume":"103","author":"Roeser","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-1119(03)00746-7","article-title":"The human SUMF1 gene, required for posttranslational sulfatase modification, defines a new gene family which is conserved from pro- to eukaryotes","volume":"316","author":"Landgrebe","year":"2003","journal-title":"Gene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.embor.7400454","article-title":"Sulphatase activities are regulated by the interaction of sulphatase-modifying factor 1 with SUMF2","volume":"6","author":"Zito","year":"2005","journal-title":"EMBO Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1107\/S0907444907009961","article-title":"Probing the oxygen-binding site of the human formylglycine-generating enzyme using halide ions","volume":"63","author":"Roeser","year":"2007","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/emboj\/18.8.2084","article-title":"Sequence determinants directing conversion of cysteine to formylglycine in eukaryotic sulfatases","volume":"18","author":"Dierks","year":"1999","journal-title":"EMBO J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1038\/onc.2013.483","article-title":"Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects","volume":"33","author":"Bhattacharyya","year":"2014","journal-title":"Oncogene"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11076","DOI":"10.1074\/jbc.RA117.001244","article-title":"Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells","volume":"293","author":"Bhattacharyya","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1165\/rcmb.2008-0482OC","article-title":"Cell-bound IL-8 increases in bronchial epithelial cells after arylsulfatase B silencing due to sequestration with chondroitin-4-sulfate","volume":"42","author":"Bhattacharyya","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bbagrm.2014.12.009","article-title":"Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A","volume":"1849","author":"Bhattacharyya","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_31","first-page":"472","article-title":"Arylsulfatase B regulates interaction of chondroitin-4-sulfate and kininogen in renal epithelial cells","volume":"1802","author":"Bhattacharyya","year":"2010","journal-title":"BBA: Mol. Basis Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"17564","DOI":"10.1074\/jbc.M114.561589","article-title":"Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3","volume":"289","author":"Bhattacharyya","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.18632\/oncotarget.13751","article-title":"Decline in arylsulfatase B leads to increased invasiveness of melanoma cells","volume":"8","author":"Bhattacharyya","year":"2017","journal-title":"Oncotarget"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10585-009-9253-z","article-title":"Arylsulfatase B regulates colonic epithelial cell migration by effects on MMP9 expression and RhoA activation","volume":"26","author":"Bhattacharyya","year":"2009","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Bhattacharyya, S., and Tobacman, J.K. (2014). Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033250"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100242","DOI":"10.18632\/oncotarget.22152","article-title":"Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1\/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3)","volume":"8","author":"Bhattacharyya","year":"2017","journal-title":"Oncotarget"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/pros.23776","article-title":"Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)-3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A","volume":"79","author":"Bhattacharyya","year":"2019","journal-title":"Prostate"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.18632\/oncotarget.27634","article-title":"Increased CHST15 follows decline in arylsulfatase B (ARSB) and disinhibition of non-canonical WNT signaling: Potential impact on epithelial and mesenchymal identity","volume":"11","author":"Bhattacharyya","year":"2020","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cca.2007.01.021","article-title":"Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR","volume":"380","author":"Bhattacharyya","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00795-009-0447-x","article-title":"Cell-surface arylsulfatase A and B on sinusoidal endothelial cells, hepatocytes, and Kupffer cells in mammalian livers","volume":"42","author":"Kusunoki","year":"2009","journal-title":"Med. Mol. Morphol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1369\/0022155410395511","article-title":"Extra-lysosomal localization of arylsulfatase B in human colonic epithelium","volume":"59","author":"Prabhu","year":"2011","journal-title":"J. Histochem. Cytochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/pcan.2013.18","article-title":"Arylsulfatase B (N-acetylgalactosamine-4-sulfatase): Potential role as a biomarker in prostate cancer","volume":"16","author":"Feferman","year":"2013","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3233\/CBM-170680","article-title":"Arylsulfatase B is reduced in prostate cancer recurrences","volume":"21","author":"Feferman","year":"2017","journal-title":"Cancer Biomark."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Bhattacharyya, S., Solakyildirim, K., Zhang, Z., Linhardt, R.J., and Tobacman, J.K. (2009). Chloroquine reduces arylsulphatase B activity and increases chondroitin-4-sulphate: Implications for mechanisms of action and resistance. Malar. J., 8.","DOI":"10.1186\/1475-2875-8-303"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00490367","article-title":"Fine structural localization of arylsulfatase B activity in the rabbit blood platelets","volume":"44","author":"Murata","year":"1975","journal-title":"Histochemistry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02145887","article-title":"Ultrastructural localization of arylsulfatase B in mitochondria of epithelial cells of the proximal convoluted tubules of the rat kidney","volume":"27","author":"Makita","year":"1971","journal-title":"Experientia"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.joca.2014.05.012","article-title":"Changes in the metabolism of chondroitin sulfate glycosaminoglycans in articular cartilage from patients with Kashin-Beck disease","volume":"22","author":"Luo","year":"2014","journal-title":"Osteoarthr. Cartil."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0005-2744(77)90287-X","article-title":"Arylsulfatase of human tissue. Studies on a form of arylsulfatase B found predominantly in brain","volume":"481","author":"Stevens","year":"1977","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-8993(87)90577-4","article-title":"Cellular localization of soluble and membrane-bound forms of arylsulfatase in rat brain","volume":"419","author":"Kung","year":"1987","journal-title":"Brain Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0005-2744(80)90234-X","article-title":"Soluble arylsulfatases of human brain and some characteristics of the brain-specific arylsulfatase Bm","volume":"614","author":"Lakshmi","year":"1980","journal-title":"Biochim. Biophys. Acta."},{"key":"ref_51","unstructured":"(2022, October 01). The Human Protein Atlas. Available online: https:\/\/www.proteinatlas.org\/ENSG00000113273-ARSB\/tissue."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Bhattacharyya, S., Feferman, L., and Tobacman, J.K. (2016). Restriction of aerobic metabolism by acquired or innate Arylsulfatase B deficiency: A new approach to the Warburg effect. Sci. Rep., 6.","DOI":"10.1038\/srep32885"},{"key":"ref_53","first-page":"421","article-title":"4-Nitrocatechol sulfate as a substrate for the assay of aryl sulfatase","volume":"2","author":"Dzialoszynski","year":"1955","journal-title":"Acta Biochim. Pol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0076-6879(87)43039-5","article-title":"Arylsulfatases, colorimetric and fluorimetric assays","volume":"143","author":"Roy","year":"1987","journal-title":"Methods Enzymol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ab.2009.08.012","article-title":"Development of a functional bioassay for arylsulfatase B using the natural substrates of the enzyme","volume":"395","author":"Pungor","year":"2009","journal-title":"Anal. Biochem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cca.2015.08.010","article-title":"Fluorimetric assays for N-acetylgalactosamine-6-sulfatase and arylsulfatase B based on the natural substrates for confirmation of mucopolysaccharidoses types IVA and VI","volume":"451","author":"Kumar","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cccn.2004.10.009","article-title":"Development of an assay for the detection of mucopolysaccharidosis type VI patients using dried blood-spots","volume":"353","author":"Hein","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ymgme.2007.10.010","article-title":"In vivo specific reduction of arylsulfatase B enzymatic activity in children with cystic fibrosis","volume":"94","author":"Ferrero","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0005-2744(79)90035-4","article-title":"The activity of arylsulfatase A and B on tyrosine O-sulfates","volume":"566","author":"Fluharty","year":"1979","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0009-8981(77)90369-2","article-title":"A microfluorometric assay of the lysosomal arylsulfatases in leukocytes","volume":"75","author":"Kelly","year":"1977","journal-title":"Clin. Chim Acta"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0009-8981(79)90247-X","article-title":"Arylsulfatases A and B in human diploid fibroblasts: Differential assay with 4-methylumbelliferylsulfate and AgNO3","volume":"93","author":"Mercelis","year":"1979","journal-title":"Clin. Chim. Acta"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0003-2697(81)90795-8","article-title":"Differential assay of arylsulfatases A and B activities: A sensitive method for cultured human cells","volume":"117","author":"Chang","year":"1981","journal-title":"Anal. Biochem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0167-4838(84)90297-8","article-title":"Inhibition of rabbit liver arylsulfatase B by phosphate esters","volume":"788","author":"Rao","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1768-322X.1986.tb00471.x","article-title":"Lysosomal arylsulfatases A and B from horse blood leukocytes: Purification and physico-chemical properties","volume":"57","year":"1986","journal-title":"Biol. Cell"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0009-8981(59)90119-6","article-title":"The assay of arylsulphatases A and B in human urine","volume":"4","author":"Baum","year":"1959","journal-title":"Clin. Chim. Acta"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/181115a0","article-title":"Arylsulphate synthesis and the arylsulphatases","volume":"181","author":"Baum","year":"1958","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/03008207609152226","article-title":"Enzymes from human articular cartilage: Isolation of arylsulfatase B and its comparison with arylsulfatase A","volume":"4","author":"Gold","year":"1976","journal-title":"Connect Tissue Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1172\/JCI108332","article-title":"Arylsulfatase B of human lung. Isolation, characterization, and interaction with slow-reacting substance of anaphylaxis","volume":"57","author":"Wasserman","year":"1976","journal-title":"J. Clin. Investig."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/03008207609152223","article-title":"Effect of ascorbic acid on arylsulfatase A and B activities in human chondrocyte cultures","volume":"4","author":"Schwartz","year":"1976","journal-title":"Connect Tissue Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10719-013-9468-8","article-title":"Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin","volume":"30","author":"Kotlo","year":"2013","journal-title":"Glycoconj. J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jsbmb.2014.01.017","article-title":"Differential effects of estrogen exposure on arylsulfatase B, galactose-6-sulfatase, and steroid sulfatase in rat prostate development","volume":"143","author":"Feferman","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jsbmb.2006.08.002","article-title":"Steroid sulfatase, arylsulfatases A and B, galactose-6-sulfatase, and iduronate sulfatase in mammary cells and effects of sulfated and non-sulfated estrogens on sulfatase activity","volume":"103","author":"Bhattacharyya","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jnutbio.2011.05.012","article-title":"Molecular signature of kappa-carrageenan mimics chondroitin-4-sulfate and dermatan sulfate and enables interaction with arylsulfatase B","volume":"23","author":"Bhattacharyya","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.biochi.2012.02.031","article-title":"Exposure to common food additive carrageenan leads to reduced sulfatase activity and increase in sulfated glycosaminoglycans in human epithelial cells","volume":"94","author":"Yang","year":"2012","journal-title":"Biochimie"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/glia.22604","article-title":"Arylsulfatase B modulates neurite outgrowth via astrocyte chondroitin-4-sulfate: Dysregulation by ethanol","volume":"62","author":"Zhang","year":"2014","journal-title":"Glia"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.1074\/jbc.M211015200","article-title":"The low sulfated chondroitin sulfate proteoglycans of human placenta have sulfate group-clustered domains that can efficiently bind Plasmodium falciparum-infected erythrocytes","volume":"278","author":"Achur","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0002-9440(10)63761-3","article-title":"Plasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low sulfated chondroitin sulfate proteoglycan receptor","volume":"164","author":"Muthusamy","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Spliid, C.B., Toledo, A.G., Sanderson, P., Mao, Y., Gatto, F., Gustavsson, T., Choudhary, S., Saldanha, A.L., Vogelsang, R.P., and G\u00f6genur, I. (2021). The specificity of the malarial VAR2CSA protein for chondroitin sulfate depends on 4-O-sulfation and ligand accessibility. J. Biol. Chem., 297.","DOI":"10.1016\/j.jbc.2021.101391"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1038\/s41467-021-23254-1","article-title":"Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Bhattacharyya, S., Feferman, L., and Tobacman, J.K. (2019). Distinct effects of carrageenan and high-fat consumption on the mechanisms of insulin resistance in nonobese and obese models of Type 2 diabetes. J. Diabetes Res., 2019.","DOI":"10.1155\/2019\/9582714"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cell.2016.10.025","article-title":"Hematopoietic-derived galectin-3 causes cellular and systemic insulin resistance","volume":"167","author":"Li","year":"2016","journal-title":"Cell"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Feferman, L., Bhattacharyya, S., Oates, E., Haggerty, N., Wang, T., Varady, K., and Tobacman, J.K. (2020). Carrageenan-free diet shows improved glucose tolerance and insulin signaling in prediabetes: A randomized, pilot clinical trial. J. Diabetes Res., 2020.","DOI":"10.1155\/2020\/8267980"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ymgme.2018.02.012","article-title":"Increased GPNMB, phosphoRK1\/2, and MMP-9 in cystic fibrosis in association with reduced arylsulfatase B","volume":"124","author":"Bhattacharyya","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbrc.2008.05.190","article-title":"Desulfated galactosaminoglycans are potential ligands for galectins: Evidence from frontal affinity chromatography","volume":"373","author":"Iwaki","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Tobacman, J.K., Bhattacharyya, S., and Feferman, L. (2020). Decline in Arylsulfatase B (ARSB) increases PD-L1 expression in melanoma, hepatic, prostate, and mononuclear cells. Cancer Res., 80.","DOI":"10.1158\/1538-7445.AM2020-4699"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1073\/pnas.0710468105","article-title":"Specific inhibitors of the protein tyrosine phosphatase Shp2 Identified by high-throughput docking","volume":"105","author":"Hellmuth","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Tobacman, J.K., Bhattacharyya, S., and Feferman, L. (2021). Chondroitin sulfatases and transcription factors Gli, Tcf\/Lef, and c-Myc in prostate stem cells [abstract]. Cancer Res., 81.","DOI":"10.1158\/1538-7445.AM2021-2442"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ppul.22567","article-title":"Reduced arylsulfatase B activity in leukocytes from cystic fibrosis patients","volume":"48","author":"Sharma","year":"2013","journal-title":"Pediatr. Pulmonol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pupt.2015.11.005","article-title":"Effect of CFTR modifiers on arylsulfatase B activity in cystic fibrosis and normal human bronchial epithelial cells","volume":"36","author":"Bhattacharyya","year":"2016","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.steroids.2017.10.013","article-title":"Glycoprotein non-metastatic melanoma protein B (GPNMB) and cancer: A novel potential therapeutic target","volume":"133","author":"Taya","year":"2018","journal-title":"Steroids"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharmthera.2017.05.010","article-title":"Targeting GPNMB with glembatumumab vedotin: Current developments and future opportunities for the treatment of cancer","volume":"179","author":"Rose","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/00313025.2010.508735","article-title":"Frameshift mutations of ATBF1, WNT9A, CYLD, and PARK2 in gastric and colorectal carcinomas with high microsatellite instability","volume":"42","author":"An","year":"2010","journal-title":"Pathology"},{"key":"ref_93","first-page":"1221","article-title":"Expression of WNT14 and WNT14B mRNAs in human cancer, up-regulation of WNT14 by IFN \u03b3 and up-regulation of WNT14B by \u03b2-estradiol","volume":"19","author":"Kirikoshi","year":"2001","journal-title":"Int. J. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1074\/jbc.M707967200","article-title":"Distinct effects of N-acetylgalactosamine-4-sulfatase and galactose-6-sulfatase expression on chondroitin sulfates","volume":"283","author":"Bhattacharyya","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-8417-2-4","article-title":"Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI","volume":"2","author":"Tessitore","year":"2009","journal-title":"Pathogenetics"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/312467a0","article-title":"Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation","volume":"312","author":"Gasper","year":"1984","journal-title":"Nature"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1378\/chest.123.6.2130","article-title":"Does deficiency of arylsulfatase B have a role in cystic fibrosis?","volume":"123","author":"Tobacman","year":"2003","journal-title":"Chest"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.12998\/wjcc.v7.i23.3990","article-title":"Interaction of arylsulfatases A and B with maspin: A possible explanation for dysregulation of tumor cell metabolism and invasive potential of colorectal cancer","volume":"7","author":"Kovacs","year":"2019","journal-title":"World J. Clin. Cases"},{"key":"ref_99","first-page":"983","article-title":"Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer","volume":"3","author":"Ricciardelli","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"ref_100","first-page":"963","article-title":"Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer","volume":"4","author":"Ricciardelli","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10555-009-9182-y","article-title":"The biological role and regulation of versican levels in cancer","volume":"28","author":"Ricciardelli","year":"2009","journal-title":"Cancer Metastasis Rev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"E2084","DOI":"10.1210\/jc.2014-1734","article-title":"Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk","volume":"99","author":"Figlioli","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0301-2115(03)00110-6","article-title":"The activities of some glycosaminoglycan-degrading enzymes in uterine leiomyomas","volume":"110","author":"Sobolewski","year":"2003","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Yoo, M., Khaled, M., Gibbs, K.M., Kim, J., Kowalewski, B., Dierks, T., and Schachner, M. (2013). Arylsulfatase B improves locomotor function after mouse spinal cord injury. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057415"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Park, H.H., Kim, Y.M., Anh Hong, L.T., Kim, H.S., Kim, S.H., Jin, X., Hwang, D.H., Kwon, M.J., Song, S.C., and Kim, B.G. (2022). Dual-functional hydrogel system for spinal cord regeneration with sustained release of arylsulfatase B alleviates fibrotic microenvironment and promotes axonal regeneration. Biomaterials, 284.","DOI":"10.1016\/j.biomaterials.2022.121526"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Pearson, C.S., Mencio, C.P., Barber, A.C., Martin, K.R., and Geller, H.M. (2018). Identification of a critical sulfation in chondroitin that inhibits axonal regeneration. Elife, 7.","DOI":"10.7554\/eLife.37139"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1242\/jcs.032649","article-title":"Chondroitin-4-sulfation negatively regulates axonal guidance and growth","volume":"121","author":"Wang","year":"2008","journal-title":"J. Cell Sci."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Pearson, C.S., Solano, A.G., Tilve, S.M., Mencio, C.P., Martin, K.R., and Geller, H.M. (2020). Spatiotemporal distribution of chondroitin sulfate proteoglycans after optic nerve injury in rodents. Exp. Eye Res., 190.","DOI":"10.1016\/j.exer.2019.107859"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s12035-017-0406-9","article-title":"Expression and distribution of Arylsulfatase B are closely associated with neuron death in SOD1 G93A transgenic mice","volume":"55","author":"Zhang","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/jnc.13156","article-title":"Decline in arylsulfatase B and Increase in chondroitin 4-sulfotransferase combine to increase chondroitin 4-sulfate in traumatic brain injury","volume":"134","author":"Bhattacharyya","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Potkin, S.G., Guffanti, G., Lakatos, A., Turner, J.A., Kruggel, F., Fallon, J.H., Saykin, A.J., Orro, A., Lupoli, S., and Salvi, E. (2009). Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer\u2019s disease. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006501"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1046\/j.1471-4159.1999.0731477.x","article-title":"The up-regulation of endosomal-lysosomal components in amyloid beta-resistant cells","volume":"73","author":"Li","year":"1999","journal-title":"J. Neurochem."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Blake, M.R., Parrish, D.C., Staffenson, M.A., Sueda, S., Woodward, W.R., and Habecker, B.A. (2022). Chondroitin sulfate proteoglycan 4,6 sulfation regulates sympathetic nerve regeneration after myocardial infarction. eLife, 11.","DOI":"10.7554\/eLife.78387"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000519542","article-title":"Increase in chondroitin sulfate and decline in Arylsulfatase B may contribute to pathophysiology of COVID-19 respiratory failure","volume":"89","author":"Tzankov","year":"2022","journal-title":"Pathobiology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0090-1229(81)90010-6","article-title":"Sequential alterations in the human eosinophil content of arylsulfatase B during therapy of Bacroftian filariasis","volume":"18","author":"Weller","year":"1981","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_116","first-page":"223","article-title":"Activity of some hepatic enzymes in schistosomiasis and concomitant alteration of arylsulfatase B","volume":"37","author":"Balbaa","year":"2004","journal-title":"J. Biochem. Mol. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/jbmr.3563","article-title":"The lysosomal protein Arylsulfatase B Is a key enzyme involved in skeletal turnover","volume":"33","author":"Pohl","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Mechanism of glycosaminoglycan-mediated bone and joint disease: Implications for the mucopolysaccharidoses and other connective tissue diseases","volume":"172","author":"Simonaro","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/labinvest.3780345","article-title":"Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: A possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses","volume":"81","author":"Simonaro","year":"2001","journal-title":"Lab. Investig."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jor.1100040303","article-title":"Monensin stimulation of arylsulfatase B activity in human chondrocytes","volume":"4","author":"Colofiore","year":"1986","journal-title":"J. Orthop. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymgmr.2015.02.003","article-title":"Human pulmonary artery endothelial cells in the model of mucopolysaccharidosis VI present a prohypertensive phenotype used for studies of pulmonary hypertension","volume":"3","author":"Golda","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00109-018-1708-8","article-title":"Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease","volume":"96","author":"Seo","year":"2018","journal-title":"J. Mol. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000084085.65972.3F","article-title":"Cardiac and ocular pathologies in a mouse model of mucopolysaccharidosis type VI","volume":"54","author":"Strauch","year":"2003","journal-title":"Pediatr Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10545-008-0821-1","article-title":"Clinical characterization of cardiovascular abnormalities associated with feline mucopolysaccharidosis I and VI","volume":"31","author":"Sleeper","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1161\/CIRCULATIONAHA.117.030353","article-title":"Targeting chondroitin sulfate glycosaminoglycans to treat cardiac fibrosis in pathological remodeling","volume":"37","author":"Zhao","year":"2018","journal-title":"Circulation"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Wang, Q., Yu, X., Dou, L., Huang, X., Zhu, K., Guo, J., Yan, M., Wang, S., Man, Y., and Tang, W. (2019). miR-154-5p Functions as an important regulator of Angiotensin II-mediated heart remodeling. Oxid. Med. Cell. Longev., 2019.","DOI":"10.1155\/2019\/8768164"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.cellsig.2015.03.004","article-title":"Small interfering RNA therapy against carbohydrate sulfotransferase 15 inhibits cardiac remodeling in rats with dilated cardiomyopathy","volume":"27","author":"Watanabe","year":"2015","journal-title":"Cell Signal."},{"key":"ref_128","first-page":"529","article-title":"Glycosaminoglycan-degrading enzymes in the varicose vein wall","volume":"27","author":"Kowalewski","year":"2008","journal-title":"Int. Angiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1038\/s41598-017-04497-9","article-title":"Upregulation of arylsulfatase B in carotid atherosclerosis is associated with symptoms of cerebral embolization","volume":"7","author":"Biros","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/bj0680387","article-title":"Studies on sulphatases. 19. The purification and properties of arylsulphatase B of human liver","volume":"68","author":"Dodgson","year":"1958","journal-title":"Biochem. J."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/0002-9343(69)90167-3","article-title":"The nosology of the mucopolysaccharidoses","volume":"47","author":"McKusick","year":"1969","journal-title":"Am. J. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0009-8981(66)90032-5","article-title":"Arylsulphatase activity of some malignant tumors","volume":"14","author":"Kroll","year":"1966","journal-title":"Clin. Chim. Acta"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-3476(72)80467-0","article-title":"A distinct biochemical deficit in the Maroteaux-Lamy syndrome (mucopolysaccharidosis VI)","volume":"80","author":"Baron","year":"1972","journal-title":"J. Pediatr."},{"key":"ref_134","first-page":"181","article-title":"Human placenta arylsulphatase B purification and separation into subfractions","volume":"19","year":"1972","journal-title":"Acta Biochim. Pol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000211708","article-title":"The sulphokinase, arylsulphatase-B and acid phosphatase activities of carrageenin granuloma in rats of different ages","volume":"15","year":"1969","journal-title":"Gerontologia"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0006-291X(75)80159-8","article-title":"Reduced arylsulfatase B activity of the mutant enzyme protein in Maroteaux-Lamy syndrome","volume":"62","author":"Shapira","year":"1975","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1203\/00006450-197505000-00003","article-title":"Arylsulfatase B deficiency in Maroteaux-Lamy syndrome: Cellular studies and carrier identification","volume":"9","author":"Beratis","year":"1975","journal-title":"Pediatr. Res."},{"key":"ref_138","unstructured":"NORD (2022, October 01). Rare Disease Database. Available online: https:\/\/rarediseases.org\/rare-diseases\/maroteaux-lamy-syndrome\/."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/ajmg.a.36584","article-title":"Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)\u201410-year follow-up of patients who previously participated in an MPS VI Survey Study","volume":"164A","author":"Giugliani","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJM198412203112504","article-title":"Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation","volume":"311","author":"Krivit","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bmt.1702528","article-title":"Umbilical cord blood transplantation for Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI)","volume":"26","author":"Lee","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhARSB) and follow-on, open-label extension study","volume":"148","author":"Harmatz","year":"2006","journal-title":"J. Pediatr."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/bj2760499","article-title":"Restoration of arylsulphatase B activity in human mucopolysaccharidosis-type-VI fibroblasts by retroviral-vector-mediated gene transfer","volume":"276","author":"Peters","year":"1991","journal-title":"Biochem. J."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.omtm.2020.11.015","article-title":"Low incidence of hepatocellular carcinoma in mice and cats treated with systemic adeno-associated viral vectors","volume":"20","author":"Ferla","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI118617","article-title":"Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome","volume":"97","author":"Crawley","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.144321","article-title":"Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: A model of Maroteaux-Lamy syndrome","volume":"198","author":"Jezyk","year":"1977","journal-title":"Science"},{"key":"ref_147","first-page":"191","article-title":"Animal model of human disease: Mucopolysaccharidosis VI Maroteaux-Lamy syndrome, Arylsulfatase B-deficient mucopolysaccharidosis in the Siamese cat","volume":"105","author":"Haskins","year":"1981","journal-title":"Am. J. Pathol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0092-8674(03)00348-9","article-title":"The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases","volume":"113","author":"Cosma","year":"2003","journal-title":"Cell"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(03)00347-7","article-title":"Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme","volume":"113","author":"Dierks","year":"2003","journal-title":"Cell"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/BJ20061783","article-title":"SUMF1 enhances sulfatase activities in vivo in five sulfatase deficiencies","volume":"403","author":"Fraldi","year":"2007","journal-title":"Biochem. J."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1093\/hmg\/ddn161","article-title":"Multistep, sequential control of the trafficking and function of the multiple sulfatase deficiency gene product, SUMF1 by PDI, ERGIC-53 and Erp44","volume":"17","author":"Fraldi","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Schlotawa, L., Adang, L.A., Radhakrishnan, K., and Ahrens-Nicklas, R.C. (2020). Multiple Sulfatase Deficiency: A disease comprising mucopolysaccharidosis, sphingolipidosis, and more caused by a defect in posttranslational modification. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103448"},{"key":"ref_153","unstructured":"MedlinePlus (2022, October 01). Multiple Sulfatase Deficiency, Available online: https:\/\/medlineplus.gov\/genetics\/condition\/multiple-sulfatase-deficiency\/#."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/adc.51.7.563","article-title":"Is cystic fibrosis an acid mucopolysaccharidosis?","volume":"51","author":"Mukherji","year":"1976","journal-title":"Arch. Dis. Child."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(69)92289-2","article-title":"Acid mucopolysaccharides in cultured human fibroblasts","volume":"2","author":"Matalon","year":"1969","journal-title":"Lancet"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"935354","DOI":"10.3389\/fendo.2022.935354","article-title":"Trends in growth and maturation in children with cystic fibrosis throughout nine decades","volume":"13","author":"Mason","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_157","unstructured":"MedlinePlus (2022, October 01). Cystic Fibrosis, Available online: https:\/\/medlineplus.gov\/ency\/article\/000107.htm#."},{"key":"ref_158","unstructured":"NORD (2022, October 01). Rare Disease Database. Cystic Fibrosis. Available online: https:\/\/rarediseases.org\/rare-diseases\/cystic-fibrosis\/."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Bosch, L., Bosch, B., De Boeck, K., Nawrot, T., Meyts, I., Vanneste, D., Le Bourlegat, C.A., Croda, J., and da Silva Filho, L.V.R.F. (2017). Cystic fibrosis carriership and tuberculosis: Hints toward an evolutionary selective advantage based on data from the Brazilian territory. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2448-z"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1098\/rsif.2006.0154","article-title":"Evaluating candidate agents of selective pressure for cystic fibrosis","volume":"4","author":"Poolman","year":"2007","journal-title":"J. R. Soc. Interface"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: A 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1016\/j.bbamcr.2013.07.021","article-title":"Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer","volume":"1833","author":"Zhang","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/j.chest.2022.01.055","article-title":"Cancer in Cystic Fibrosis: Do Not Neglect Gynecologic Cancers","volume":"161","author":"Appelt","year":"2022","journal-title":"Chest"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/1097-0142(197512)36:6<2337::AID-CNCR2820360610>3.0.CO;2-X","article-title":"Arylsulfatase B in colorectal cancer","volume":"36","author":"Morgan","year":"1975","journal-title":"Cancer"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11888-017-0354-9","article-title":"Wnt signaling and colorectal cancer","volume":"13","author":"Schatoff","year":"2017","journal-title":"Curr. Colorectal Cancer Rep."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/1097-0142(197102)27:2<278::AID-CNCR2820270205>3.0.CO;2-Y","article-title":"Lysosomal enzyme activity in liver tissue, kidney tissue, and tumor tissue from patients with renal carcinoma","volume":"27","author":"Wahlqvist","year":"1971","journal-title":"Cancer"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0009-8981(71)90353-6","article-title":"Arylsulphatase activity of human lung, liver and kidney neoplasms","volume":"32","author":"Morgan","year":"1971","journal-title":"Clin. Chim. Acta"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0021-9258(19)75776-7","article-title":"Phosphorylation of human lysosomal arylsulfatase B by cAMP-dependent protein kinase. Different sites of phosphorylation between normal and cancer tissues","volume":"262","author":"Gasa","year":"1987","journal-title":"J. Biol. Chem."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Kovacs, Z., Jung, I., and Gurzu, S. (2019). Arylsulfatases A and B: From normal tissues to malignant tumors. Pathol. Res. Pract., 215.","DOI":"10.1016\/j.prp.2019.152516"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1620\/tjem.141.247","article-title":"The activity of arylsulphatases in serum of patients with several bullous diseases","volume":"141","author":"Igarashi","year":"1983","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000014154","article-title":"Activities of some glycosaminoglycan- degrading enzymes in Wharton\u2019s jelly and their alteration in EPH-gestosis (Pre-eclampsia)","volume":"76","author":"Romanowicz","year":"1999","journal-title":"Biol. Neonate"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3950\/jibiinkoka.92.1021","article-title":"Activity of serum arylsulfatase B in nasal allergy patients","volume":"92","author":"Takagi","year":"1989","journal-title":"Nihon Jibiinkoka Gakkai Kaiho"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0009-8981(82)90012-2","article-title":"Lysosomal enzymes in normal and leukemic B lymphocytes","volume":"118","author":"Kraaijenhagen","year":"1982","journal-title":"Clin. Chim. Acta"},{"key":"ref_174","first-page":"5618","article-title":"Lysosomal arylsulfatases of human leukocytes: Increment of phosphorylated B variants in chronic myelogenous leukemia","volume":"43","author":"Uehara","year":"1983","journal-title":"Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/13146\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:05:29Z","timestamp":1760144729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/13146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":174,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijms232113146"],"URL":"https:\/\/doi.org\/10.3390\/ijms232113146","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202209.0115.v1","asserted-by":"object"}]},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,29]]}}}